Turtle Beach (TBCH) 10-Q 4 May 22 2022 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2022	Apr. 30, 2022
Cover [Abstract]
Entity Registrant Name	TURTLE BEACH CORPORATION
Entity Central Index Key	0001493761
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Document Type	10-Q
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		16,479,134
Entity Shell Company	false
Trading Symbol	HEAR
Entity Current Reporting Status	Yes
Entity File Number	001-35465
Entity Tax Identification Number	27-2767540
Entity Address, Address Line One	44 South Broadway
Entity Address, Address Line Two	4th Floor
Entity Address, City or Town	White Plains
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10601
City Area Code	888
Local Phone Number	496-8001
Entity Incorporation, State or Country Code	NV
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock, par value $0.001
Security Exchange Name	NASDAQ

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Net revenue	$ 46,662	$ 93,053
Cost of revenue	32,633	58,198
Gross profit	14,029	34,855
Operating expenses:
Selling and marketing	10,829	11,545
Research and development	5,252	3,993
General and administrative	6,235	7,037
Total operating expenses	22,316	22,575
Operating income (loss)	(8,287)	12,280
Interest expense	109	97
Other non-operating expense, net	719	579
Income (loss) before income tax	(9,115)	11,604
Income tax expense (benefit)	(2,639)	2,766
Net income (loss)	$ (6,476)	$ 8,838
Net income (loss) per share
Basic (in dollars per share)	$ (0.40)	$ 0.57
Diluted (in dollars per share)	$ (0.40)	$ 0.49
Weighted average number of shares:
Basic (in shares)	16,194	15,551
Diluted (in shares)	16,194	18,076

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ (6,476)	$ 8,838
Foreign currency translation adjustment	(429)	(711)
Other comprehensive income (loss)	(429)	(711)
Comprehensive income (loss)	$ (6,905)	$ 8,127

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 23,700	$ 37,720
Accounts receivable, net	11,814	35,953
Inventories	117,422	101,933
Prepaid expenses and other current assets	15,773	17,506
Total Current Assets	168,709	193,112
Property and equipment, net	6,293	6,955
Deferred income taxes	8,229	5,899
Goodwill	10,686	10,686
Intangible assets, net	5,464	5,788
Other assets	8,669	8,065
Total Assets	208,050	230,505
Current Liabilities:
Accounts payable	32,899	40,475
Other current liabilities	27,385	37,693
Total Current Liabilities	60,284	78,168
Income tax payable	3,774	3,774
Other liabilities	7,630	7,194
Total Liabilities	71,688	89,136
Commitments and Contingencies
Stockholders’ Equity
Common stock, $0.001 par value - 25,000,000 shares authorized; 16,244,625 and 16,168,147 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	16	16
Additional paid-in capital	200,176	198,278
Accumulated deficit	(63,528)	(57,052)
Accumulated other comprehensive income (loss)	(302)	127
Total Stockholders’ Equity	136,362	141,369
Total Liabilities and Stockholders’ Equity	$ 208,050	$ 230,505

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Common stock par value (in dollars per share)	$ 0.001	$ 0.001
Common stock shares authorized	25,000,000	25,000,000
Common stock shares issued	16,244,625	16,168,147
Common stock shares outstanding	16,244,625	16,168,147

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (6,476,000)	$ 8,838,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	1,192,000	739,000
Amortization of intangible assets	312,000	303,000
Amortization of debt financing costs	47,000	47,000
Stock-based compensation	1,537,000	1,786,000
Deferred income taxes	(2,329,000)	(388,000)
Change in sales returns reserve	(3,285,000)	678,000
Provision for obsolete inventory	(874,000)	57,000
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	27,423,000	10,819,000
Inventories	(14,615,000)	12,108,000
Accounts payable	(7,494,000)	(15,669,000)
Prepaid expenses and other assets	1,734,000	(6,568,000)
Income taxes payable	(657,000)	3,086,000
Other liabilities	(9,863,000)	5,251,000
Net cash provided by (used for) operating activities	(13,348,000)	21,087,000
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment	(611,000)	(2,280,000)
Acquisition of a business, net of cash acquired		(2,500,000)
Net cash used for investing activities	(611,000)	(4,780,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings on revolving credit facilities		97,032,000
Repayment of revolving credit facilities		(97,032,000)
Proceeds from exercise of stock options and warrants	361,000	911,000
Repurchase of common stock to satisfy employee tax withholding obligations		(215,000)
Net cash provided by financing activities	361,000	696,000
Effect of exchange rate changes on cash and cash equivalents	(422,000)	(719,000)
Net increase (decrease) in cash and cash equivalents	(14,020,000)	16,284,000
Cash and cash equivalents - beginning of period	37,720,000	46,681,000
Cash and cash equivalents - end of period	23,700,000	62,965,000
SUPPLEMENTAL DISCLOSURE OF INFORMATION
Cash paid for interest	64,000	64,000
Cash paid for income taxes	$ 126,000	$ 5,000

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Common stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2020	$ 116,399	$ 15	$ 190,568	$ (74,773)	$ 589
Beginning Balance, shares at Dec. 31, 2020		15,476,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	8,838			8,838
Other comprehensive loss, net of tax	(711)				(711)
Issuance of restricted stock	113		113
Issuance of restricted stock, shares		26,000
Stock options exercised	912	$ 1	911
Stock options exercised, shares		159,000
Stock-based compensation	1,786		1,786
Repurchase of common stock and retirement of related treasury shares	(215)		(215)
Repurchase of common stock and retirement of related treasury shares, shares		(6,000)
Ending Balance at Mar. 31, 2021	127,122	$ 16	193,163	(65,935)	(122)
Ending Balance, shares at Mar. 31, 2021		15,655,000
Beginning Balance at Dec. 31, 2021	141,369	$ 16	198,278	(57,052)	127
Beginning Balance, shares at Dec. 31, 2021		16,168,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(6,476)			(6,476)
Other comprehensive loss, net of tax	(429)				(429)
Issuance of restricted stock, shares		30,000
Stock options exercised	$ 361		361
Stock options exercised, shares	47,078	47,000
Stock-based compensation	$ 1,537		1,537
Ending Balance at Mar. 31, 2022	$ 136,362	$ 16	$ 200,176	$ (63,528)	$ (302)
Ending Balance, shares at Mar. 31, 2022		16,245,000

Background and Basis of Present

Background and Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Background and Basis of Presentation	Note Organization Turtle Beach Corporation (“Turtle Beach” or the “Company”), headquartered in White Plains, New York and incorporated in the state of Nevada in 2010, is a premier audio and gaming technology company with expertise and experience in developing, commercializing and marketing innovative products across a range of large addressable markets under the Turtle Beach®, ROCCAT® and Neat Microphones® brands. Turtle Beach is a worldwide leader of feature-rich headset solutions for use across multiple platforms, including video game and entertainment consoles, handheld consoles, personal computers (“PC”), tablets and mobile devices. ROCCAT is a gaming keyboards, mice and other accessories brand focused on the PC peripherals market. Neat Microphones is a microphones brand focused on using cutting edge technology and design to create high quality USB and analog microphones for gamers, streamers, and professionals. VTB Holdings, Inc. (“VTBH”), a wholly-owned subsidiary of Turtle Beach Corporation and the owner of Voyetra Turtle Beach, Inc. (“VTB”), was incorporated in the state of Delaware in 2010. VTB, the owner of Turtle Beach Europe Limited (“TB Europe”), was incorporated in the state of Delaware in 1975 with operations principally located in White Plains, New York. Basis of Presentation The accompanying interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, in the opinion of management, reflect all adjustments (which include normal recurring adjustments) considered necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods presented. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and footnote disclosures, normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), have been condensed or omitted pursuant to those rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading. The results of operations for the interim periods are not necessarily indicative of the results of operations for the entire fiscal year. The December 31, 2021 Condensed Consolidated Balance Sheet has been derived from the Company’s audited financial statements included in its Annual Report on Form 10-K filed with the SEC on March 2, 2022 (“Annual Report”). These financial statements should be read in conjunction with the annual financial statements and the notes thereto included in the Annual Report that contains information useful to understanding the Company’s businesses and financial statement presentations. Use of estimates : The preparation of accompanying unaudited consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the consolidated financial statements in the period in which such changes occur. Future actual results could differ materially from these estimates. The novel coronavirus (“COVID-19”) pandemic has disrupted worldwide economic markets and the extent to which COVID-19 continues to affect the Company’s business, results of operations and financial condition will depend on future developments, which are highly uncertain and difficult to predict. We continue to actively monitor and assess the impact of the pandemic on our business, operations, and financial condition.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note The preparation of consolidated annual and quarterly financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Company’s consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company can give no assurance that actual results will not differ from those estimates. There have been no material changes to the critical accounting policies and estimates from the information provided in Note 1 of the notes to our consolidated financial statements in our Annual Report.

Fair Value Measurement

Fair Value Measurement	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurement	Note 3. Fair Value Measurement The Company follows a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: • Level 1 — Quoted prices in active markets for identical assets or liabilities. • Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for markets that are not active, or other inputs that are observable or can be corroborated by observable market data. • Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, debt instruments and certain warrants. As of March 31, 2022 and December 31, 2021, the Company had not elected the fair value option for any financial assets and liabilities for which such an election would have been permitted March 31, 2022 December 31, 2021 Reported Fair Value Reported Fair Value (in thousands) Financial Assets and Liabilities: Cash and cash equivalents $ 23,700 $ 23,700 $ 37,720 $ 37,720 Cash equivalents are stated at amortized cost, which approximates fair value as of the consolidated balance sheet dates, due to the short period of time to maturity; and accounts receivable and accounts payable are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment.

Allowance for Sales Returns

Allowance for Sales Returns	3 Months Ended
	Mar. 31, 2022
Allowance For Sales Returns [Abstract]
Allowance for Sales Returns	Note The following table provides the changes in our sales return reserve, which is classified as a reduction of accounts receivable: Three Months Ended March 31, 2022 2021 (in thousands) Balance, beginning of period $ 8,998 $ 11,233 Reserve accrual 2,683 6,551 Recoveries and deductions, net (5,968 ) (5,873 ) Balance, end of period $ 5,713 $ 11,911

Composition of Certain Financia

Composition of Certain Financial Statement Items	3 Months Ended
	Mar. 31, 2022
Condensed Consolidated Balance Sheet Components [Abstract]
Composition of Certain Financial Statement Items	Note Inventories Inventories consist of the following: March 31, 2022 December 31, 2021 (in thousands) Finished goods $ 116,811 $ 101,446 Raw materials 611 487 Total inventories $ 117,422 $ 101,933 Property and Equipment, net Property and equipment, net, consists of the following: March 31, 2022 December 31, 2021 (in thousands) Machinery and equipment $ 2,317 $ 2,255 Software and software development 2,406 2,404 Furniture and fixtures 1,422 1,257 Tooling 8,036 7,855 Leasehold improvements 1,752 1,794 Demonstration units and convention booths 14,657 14,493 Total property and equipment, gross 30,590 30,058 Less: accumulated depreciation and amortization (24,297 ) (23,103 ) Total property and equipment, net $ 6,293 $ 6,955 Other Current Liabilities Other current liabilities consist of the following: March 31, 2022 December 31, 2021 (in thousands) Accrued royalty 8,261 11,582 Accrued employee expenses 4,328 4,114 Accrued freight 4,028 6,251 Accrued marketing 2,411 3,723 Accrued expenses 8,357 12,023 Total other current liabilities $ 27,385 $ 37,693

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Note Acquired Intangible Assets Acquired identifiable intangible assets, and related accumulated amortization, as of March 31, 2022 and December 31, 2021 consist of: March 31, 2022 Gross Carrying Value Accumulated Amortization Net Book Value (in thousands) Customer relationships $ 8,355 $ 6,491 $ 1,864 Tradenames 3,066 807 2,259 Developed technology 1,884 507 1,377 Foreign currency (1,025 ) (989 ) (36 ) Total Intangible Assets $ 12,280 $ 6,816 $ 5,464 December 31, 2021 Gross Carrying Value Accumulated Amortization Net Book Value (in thousands) Customer relationships $ 8,355 $ 6,315 $ 2,040 Tradenames 3,066 730 2,336 Developed technology 1,884 440 1,444 Foreign currency (896 ) (865 ) (32 ) Total Intangible Assets $ 12,409 $ 6,620 $ 5,788 In connection with the October 2012 acquisition of TB Europe, the acquired intangible assets related to customer relationships is being amortized over an estimated useful life of thirteen years with the amortization being included within sales and marketing expense. In May 2019, the Company completed its acquisition of the business and assets of the ROCCAT business, and in January 2021, the Company completed its acquisition of the business and assets of the Neat Microphones business. The respective acquired intangible assets relating to developed technology, customer relationships and trade names are subject to amortization. Amortization expense related to definite lived intangible assets was $0.3 million for each of the three months ended March 31, 2022 and March 31, 2021. As of March 31, 2022, estimated annual amortization expense related to definite lived intangible assets in future periods is as follows: (in thousands) 2022 $ 961 2023 1,041 2024 1,008 2025 889 2026 637 Thereafter 964 Total $ 5,500 There were no changes in the carrying values of goodwill for the three months ended March 31, 2022 from the balance as of December 31, 2021.

Revolving Credit Facility and L

Revolving Credit Facility and Long-Term Debt	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Revolving Credit Facility and Long-Term Debt	Note The Company had no outstanding balance related to its revolving credit facility as of March 31, 2022 and December 31, 2021. Total interest expense, inclusive of amortization of deferred financing costs, on long-term debt obligations was $0.1 million for each of the three months ended March 31, 2022 and March 31, 2021. Amortization of deferred financing costs was $47,000 for each of the three months ended March 31, 2022 and March 31, 2021. Revolving Credit Facility On December 17, 2018, Turtle Beach and certain of its subsidiaries entered into an amended and restated loan, guaranty and security agreement (“Credit Facility”) with Bank of America, N.A. (“Bank of America”), as Agent, Sole Lead Arranger and Sole Bookrunner, which replaced the then existing asset-based revolving loan agreement. The Credit Facility, which expires on March 5, 2024, provides for a line of credit of up to $80 million inclusive of a sub-facility limit of $12 million for TB Europe, a wholly-owned subsidiary of Turtle Beach. In addition, the Credit Facility provides for a $40 million accordion feature and the ability to increase the borrowing base with a “first-in, last-out” loan (a “FILO Loan”) of up to $6.8 million. On May 31, 2019, the Company amended the Credit Facility to provide for, amongst other items, (i) the addition of TBC Holding Company LLC, a wholly-owned subsidiary of VTB, as an obligor and (ii) the ability to make investments in TB Germany GmbH, a wholly-owned subsidiary of TB Europe, of up to $4 million in connection with the acquisition of the business of ROCCAT and up to an additional $4 million annually. The maximum credit availability for loans and letters of credit under the Credit Facility is governed by a borrowing base determined by the application of specified percentages to certain eligible assets, primarily eligible trade accounts receivable and inventories, and is subject to discretionary reserves and revaluation adjustments. The Credit Facility may be used for working capital, the issuance of bank guarantees, letters of credit and other corporate purposes. Amounts outstanding under the Credit Facility bear interest at a rate equal to either a rate published by Bank of America or the LIBOR rate, plus in each case, an applicable margin, which is between 0.50% to 1.25% for base rate loans and between 1.25% to 2.00% for U.S. LIBOR loans and U.K. loans, and between 2.00% to 2.75% for the FILO Loan. In addition, Turtle Beach is required to pay a commitment fee on the unused revolving loan commitment at a rate ranging from 0.25% to 0.50% and letter of credit fees and agent fees. As of March 31, 2022, interest rates for outstanding borrowings were 4.00% for base rate loans and 3.00% for LIBOR rate loans. As of March 31, 2022, there were no outstanding borrowings under the Credit Facility. The Company is subject to quarterly financial covenant testing if certain availability thresholds are not met or certain other events occur (as defined in the Credit Facility). At such times, the Credit Facility requires the Company and its restricted subsidiaries to maintain a fixed charge coverage ratio of at least 1.00 to 1.00 as of the last day of each fiscal quarter. The Credit Facility also contains affirmative and negative covenants that, subject to certain exceptions, limit our ability to take certain actions, including the Company’s ability to incur debt, pay dividends and repurchase stock, make certain investments and other payments, enter into certain mergers and consolidations, engage in sale leaseback transactions and transactions with affiliates, and encumber and dispose of assets. Obligations under the Credit Facility are secured by a security interest and lien upon substantially all of the Company’s assets. As of March 31, 2022, the Company was in compliance with all financial covenants under the Credit Facility, as amended, and excess borrowing availability was approximately $48.7 million.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note In order to determine the quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions. However, to the extent that application of the estimated annual effective tax rate is not representative of the quarterly portion of actual tax expense expected to be recorded for the year, the Company determines the provision for income taxes based on actual year-to-date income (loss). Certain significant or unusual items are separately recognized as discrete items in the period during which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The following table presents the Company’s income tax expense and effective income tax rate: Three Months Ended March 31, 2022 2021 (in thousands) Income tax expense (benefit) $ (2,639 ) $ 2,766 Effective income tax rate 29.0 % 23.8 % Income tax benefit for the three months ended March 31, 2022 was $2.6 million at an effective tax rate of 29.0% and income tax expense for the three months ended March 31, 2021 was $2.8 million at an effective tax rate of 23.8%. The effective tax rate for the three months ended March 31, 2022 was primarily impacted by certain non-deductible costs and state income tax expense, offset by the deduction for foreign derived intangible income and stock option exercises. The Company is subject to income taxes domestically and in various foreign jurisdictions. Significant judgment is required in evaluating uncertain tax positions and determining the provision for income taxes. The Company recognizes only those tax positions that meet the more-likely-than-not recognition threshold and establishes tax reserves for uncertain tax positions that do not meet this threshold. Interest and penalties associated with income tax matters are included in the provision for income taxes in the condensed consolidated statements of operations. As of March 31, 2022, the Company had uncertain tax positions of $3.8 million, inclusive of $1.1 million of interest and penalties. The Company files U.S., state and foreign income tax returns in jurisdictions with various statutes of limitations. The federal tax years open under the statute of limitations are 2018 through 2020, and the state tax years open under the statute of limitations are 2017 through 2020.

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-Based Compensation	Note Total estimated stock-based compensation expense for employees and non-employees, related to all of the Company’s stock-based awards, was as follows: Three Months Ended March 31, 2022 2021 (in thousands) Cost of revenue $ 26 $ 397 Selling and marketing 398 331 Research and development 283 249 General and administrative 830 809 Total stock-based compensation $ 1,537 $ 1,786 The following table presents the stock activity and the total number of shares available for grant as of March 31, 2022: (in thousands) Balance at December 31, 2021 998 Options cancelled 5 Restricted stock granted (43 ) Forfeited/Expired restricted stock added back 5 Balance at March 31, 2022 965 Stock Option Activity Options Outstanding Number of Shares Underlying Outstanding Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value (in years) Outstanding at December 31, 2021 1,739,240 $ 7.72 $ 7.02 $ 25,542,823 Options Granted - - Options Exercised (47,078 ) 7.67 Options Forfeited (5,198 ) 16.27 Outstanding at March 31, 2022 1,686,964 $ 7.70 6.64 $ 23,231,263 Vested and expected to vest at March 31, 2022 1,666,854 $ 7.75 6.62 $ 22,967,200 Exercisable at March 31, 2022 1,075,419 $ 7.08 6.15 $ 15,595,467 Stock options are time-based and the majority are exercisable within 10 years of the date of grant, but only to the extent they have vested. The options generally vest as specified in the option agreements subject to acceleration in certain circumstances. In the event participants in the plan cease to be employed or engaged by the Company, all vested options would be forfeited if they are not exercised within 90 days. Forfeitures on option grants are estimated at 10% for non-executives and 0% for executives based on evaluation of historical and expected future turnover. Stock-based compensation expense was recorded net of estimated forfeitures, such that expense was recorded only for those stock-based awards expected to vest. The Company reviews this assumption periodically and will adjust it if it is not representative of future forfeiture data and trends within employee types (executive vs. non-executive). Aggregate intrinsic value represents the difference between the estimated fair value of the underlying common stock and the exercise price of outstanding, in-the-money options. The aggregate intrinsic value of options exercised was $0.5 million for the three months ended March 31, 2022. The Company uses the Black-Scholes option-pricing model to estimate the fair value of options granted as of the grant date. There were no new options granted during the three months ended March 31, 2022. The total estimated fair value of employee options vested during the three months ended March 31, 2022 was $3.1 million. As of March 31, 2022, total unrecognized compensation cost related to non-vested stock options granted to employees was $2.5 million, which is expected to be recognized over a remaining weight average vesting period of 1.8 years. Restricted Stock Activity Shares Weighted Average Grant Date Fair Value Per Share Nonvested restricted stock at December 31, 2021 788,454 $ 16.81 Granted 42,900 23.21 Vested (29,400 ) 20.88 Shares forfeited (4,587 ) 18.75 Nonvested restricted stock at March 31, 2022 797,367 $ 17.00 As of March 31, 2022 , total unrecognized compensation cost s related to the nonvested restricted stock awards was $10.2 million , which will be recognized over a remaining weighted average vesting period of 2.3 years . Performance-Based Restricted Share Units As of March 31, 2022, the Company had 134,000 performance-based restricted share units outstanding. The vesting of performance-based restricted share units is determined over a three-year

Net Income (Loss) Per Share

Net Income (Loss) Per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Note The following table sets forth the computation of basic and diluted net income per share of common stock attributable to common stockholders: Three Months Ended March 31, 2022 2021 (in thousands, except per-share data) Net income (loss) $ (6,476 ) $ 8,838 Weighted average common shares outstanding — Basic 16,194 15,551 Plus incremental shares from assumed conversions: Dilutive effect of restricted stock — 517 Dilutive effect of stock options — 1,458 Dilutive effect of warrants — 550 Weighted average common shares outstanding — Diluted 16,194 18,076 Net income (loss) per share: Basic $ (0.40 ) $ 0.57 Diluted $ (0.40 ) $ 0.49 Incremental shares from stock options and restricted stock awards are computed using the treasury stock method. The weighted average shares listed below were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented or were otherwise excluded under the treasury stock method. The treasury stock method calculates dilution assuming the exercise of all in-the-money options and vesting of restricted stock, reduced by the repurchase of shares with the proceeds from the assumed exercises and unrecognized compensation expense for outstanding awards. Three Months Ended March 31, 2022 2021 (in thousands) Stock options 1,725 97 Unvested restricted stock awards 793 3 Warrants 550 - Total 3,068 100

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segment Information	Note The following table represents total net revenues based on where customers are physically located: Three Months Ended March 31, 2022 2021 (in thousands) North America $ 31,368 $ 64,135 Europe and Middle East 12,122 26,343 Asia Pacific 3,172 2,575 Total net revenues $ 46,662 $ 93,053

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note Litigation The Company is subject to various legal proceedings and claims that arise in the ordinary course of its business. Although the amount of any liability that could arise with respect to these actions cannot be determined with certainty, in the Company’s opinion, any such liability will not have a material adverse effect on its consolidated financial position, consolidated results of operations or liquidity. Shareholders Class Action : On August 5, 2013, VTBH and the Company (f/k/a Parametric Sound Corporation) announced that they had entered into the Merger Agreement pursuant to which VTBH would acquire an approximately 80% ownership interest and existing shareholders would maintain an approximately 20% ownership interest in the combined company (the “Merger”). Following the announcement, several shareholders filed class action lawsuits in California and Nevada seeking to enjoin the Merger. The plaintiffs in each case alleged that members of the Company’s Board of Directors breached their fiduciary duties to the shareholders by agreeing to a merger that allegedly undervalued the Company. VTBH and the Company were named as defendants in these lawsuits under the theory that they had aided and abetted the Company’s Board of Directors in allegedly violating their fiduciary duties. The plaintiffs in both cases sought a preliminary injunction seeking to enjoin closing of the Merger, which, by agreement, was heard by the Nevada court with the California plaintiffs invited to participate. On December 26, 2013, the court in the Nevada case denied the plaintiffs’ motion for a preliminary injunction. Following the closing of the Merger, the Nevada plaintiffs filed a second amended complaint, which made essentially the same allegations and sought monetary damages as well as an order rescinding the Merger. The California plaintiffs dismissed their action without prejudice, and sought to intervene in the Nevada action, which was granted. Subsequent to the intervention, the plaintiffs filed a third amended complaint, which made essentially the same allegations as prior complaints and sought monetary damages. On June 20, 2014, VTBH and the Company moved to dismiss the action, but that motion was denied on August 28, 2014. On September 14, 2017, a unanimous en banc panel of the Nevada Supreme Court granted defendants’ petition for writ of mandamus and ordered the trial court to dismiss the complaint but provided a limited basis upon which plaintiffs could seek to amend their complaint. Plaintiffs amended their complaint on December 1, 2017 to assert the same claims in a derivative capacity on behalf of the Company, as a well as in a direct capacity, against VTBH, Stripes Group, LLC, SG VTB Holdings, LLC, and the former members of the Company’s Board of Directors. All defendants moved to dismiss this amended complaint on January 2, 2018, and those motions were denied on March 13, 2018. Defendants petitioned the Nevada Supreme Court to reverse this ruling on April 18, 2018. On June 15, 2018, the Nevada Supreme Court denied defendants’ writ petition without prejudice. The district court subsequently entered a pretrial schedule and set trial for November 2019. On January 18, 2019, the district court certified a class of shareholders of the Company as of January 15, 2014. On October 11, 2019, the parties notified the district court that they had reached a settlement that would resolve the pending action if ultimately approved by the Court. On January 13, 2020, the district court preliminarily approved the settlement between the plaintiffs and all defendants. A final hearing was held on May 18, 2020, wherein the Court approved the settlement and entered final judgment. On May 22, 2020, PAMTP LLC, which purports to hold the claims of eight shareholders who opted out of the class settlement described above, brought suit against the Company, the Company’s CEO, Juergen Stark, Stripes Group, LLC, SG VTB Holdings, LLC, Kenneth Fox, and former members of the Company’s Board of Directors in Nevada state court. This opt-out action asserts the same direct claims that were asserted by the class of shareholders described above. The defendants filed two motions to dismiss this complaint, which were heard on August 10, 2020. The Court denied those motions by order of August 20, 2020. The case was tried in August 2021 and all defendants, including the Company, prevailed on all counts with final judgment entered in their favor on September 3, 2021. Plaintiff has filed a notice of their intent to appeal the judgment. Defendants have pending motions to obtain their costs and fees in successfully defending against the claims, which were heard in December 2021. Employment Litigation: On April 20, 2017, a former employee filed an action in the Superior Court for the County of San Diego, State of California. The complaint alleges claims including wrongful termination, retaliation and various other provisions of the California Labor Code. The complaint seeks unspecified economic and non-economic losses, as well as allegedly unpaid wages, unreimbursed business expenses statutory penalties, interest, punitive damages and attorneys’ fees. The Company filed a cross-complaint against the former employee on May 25, 2017 for certain activities related to his employment with the Company. The matter was tried between September 24 and October 7, 2021. On October 8, 2021 a jury rendered a unanimous verdict in favor of the Company on the employment claims. The Court granted a directed verdict to the Company on its Cross- Complaint against the former employee. Judgment was entered in favor of the Company on October 27, 2021. On December 20, 2021, the former employee filed a notice of appeal of the judgment. Intellectual Property Dispute: On November 24, 2020, ABP Technology Limited (ABP) issued a claim for trademark infringement in the High Court of England and Wales against Voyetra Turtle Beach, Inc. (“VTB”) and Turtle Beach Europe Limited (“TBEU”) relating to the use by VTB and TBEU of the sign STEALTH on and in relation to gaming headsets in the UK. VTB and TBEU filed and served a Defense to the claim on February 2, 2021. On March 31, 2021, ABP filed an application for summary judgement. The summary judgment application was heard by the Court in November 2021 and was dismissed. The next stage in the main proceedings will be a Case Management Conference on June 13, 2022 at which the Court will give directions for each stage to trial. The trial is expected to be set for late 2022/early 2023. The Company will continue to vigorously defend itself in the foregoing unresolved matters. However, litigation and investigations are inherently uncertain. Accordingly, the Company cannot predict the outcome of these matters. The Company has not recorded any accrual at March 31, 2022 for contingent losses associated with these matters based on its belief that losses, while possible, are not probable. Further, any possible range of loss cannot be reasonably estimated at this time. The unfavorable resolution of these matters could have a material adverse effect on the Company’s business, results of operations, financial condition, or cash flows. The Company is engaged in other legal actions, not described above, arising in the ordinary course of its business and, while there can be no assurance, believes that the ultimate outcome of these other legal actions will not have a material adverse effect on its business, results of operations, financial condition, or cash flows. Warranties The Company warrants its products against certain manufacturing and other defects. These product warranties are provided for specific periods of time depending on the nature of the product. Warranties are generally fulfilled by replacing defective products with new products. The following table provides the changes in our product warranty reserve, which are included in accrued liabilities: Three Months Ended March 31, 2022 2021 (in thousands) Warranty, beginning of period $ 856 $ 1,039 Warranty costs accrued 121 334 Settlements of warranty claims (188 ) (255 ) Warranty, end of period $ 789 $ 1,118 Operating Leases - Right of Use Assets The Company adopted ASU 2016-02, Leases The components of the right-of-use assets and lease liabilities were as follows: Balance Sheet Classification March 31, 2022 (in thousands) Right-of-use assets Other assets $ 8,100 Lease liability obligations, current Other current liabilities $ 1,075 Lease liability obligations, noncurrent Other liabilities 7,430 Total lease liability obligations $ 8,505 Weighted-average remaining lease term (in years) 5.6 Weighted-average discount rate 4.00 % During the three months ended March 31, 2022, the Company recognized approximately $0.4 million of lease costs in operating expenses and approximately $0.2 million of operating cash flows from operating leases. Approximate future minimum lease payments for the Company’s right of use assets over the remaining lease periods as of March 31, 2022, are as follows: (in thousands) 2022 $ 986 2023 1,308 2024 1,329 2025 1,315 2026 1,217 Thereafter 3,695 Total minimum payments 9,850 Less: Imputed interest (1,345 ) Total $ 8,505

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, in the opinion of management, reflect all adjustments (which include normal recurring adjustments) considered necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods presented. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and footnote disclosures, normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), have been condensed or omitted pursuant to those rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading. The results of operations for the interim periods are not necessarily indicative of the results of operations for the entire fiscal year. The December 31, 2021 Condensed Consolidated Balance Sheet has been derived from the Company’s audited financial statements included in its Annual Report on Form 10-K filed with the SEC on March 2, 2022 (“Annual Report”). These financial statements should be read in conjunction with the annual financial statements and the notes thereto included in the Annual Report that contains information useful to understanding the Company’s businesses and financial statement presentations.
Use of Estimates	Use of estimates : The preparation of accompanying unaudited consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the consolidated financial statements in the period in which such changes occur. Future actual results could differ materially from these estimates. The novel coronavirus (“COVID-19”) pandemic has disrupted worldwide economic markets and the extent to which COVID-19 continues to affect the Company’s business, results of operations and financial condition will depend on future developments, which are highly uncertain and difficult to predict. We continue to actively monitor and assess the impact of the pandemic on our business, operations, and financial condition.

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Summary of Carrying Amounts and Estimated Fair Values of Financial Instruments	The following is a summary of the carrying amounts and estimated fair values of our financial instruments as of March 31, 2022 and December 31, 2021 March 31, 2022 December 31, 2021 Reported Fair Value Reported Fair Value (in thousands) Financial Assets and Liabilities: Cash and cash equivalents $ 23,700 $ 23,700 $ 37,720 $ 37,720

Allowance for Sales Returns (Ta

Allowance for Sales Returns (Tables)	3 Months Ended
	Mar. 31, 2022
Allowance For Sales Returns [Abstract]
Schedule of Allowances for Sales Returns	The following table provides the changes in our sales return reserve, which is classified as a reduction of accounts receivable: Three Months Ended March 31, 2022 2021 (in thousands) Balance, beginning of period $ 8,998 $ 11,233 Reserve accrual 2,683 6,551 Recoveries and deductions, net (5,968 ) (5,873 ) Balance, end of period $ 5,713 $ 11,911

Composition of Certain Financ_2

Composition of Certain Financial Statement Items (Tables)	3 Months Ended
	Mar. 31, 2022
Condensed Consolidated Balance Sheet Components [Abstract]
Schedule of Inventory	Inventories consist of the following: March 31, 2022 December 31, 2021 (in thousands) Finished goods $ 116,811 $ 101,446 Raw materials 611 487 Total inventories $ 117,422 $ 101,933
Schedule of Property and Equipment	Property and equipment, net, consists of the following: March 31, 2022 December 31, 2021 (in thousands) Machinery and equipment $ 2,317 $ 2,255 Software and software development 2,406 2,404 Furniture and fixtures 1,422 1,257 Tooling 8,036 7,855 Leasehold improvements 1,752 1,794 Demonstration units and convention booths 14,657 14,493 Total property and equipment, gross 30,590 30,058 Less: accumulated depreciation and amortization (24,297 ) (23,103 ) Total property and equipment, net $ 6,293 $ 6,955
Other Current Liabilities	Other current liabilities consist of the following: March 31, 2022 December 31, 2021 (in thousands) Accrued royalty 8,261 11,582 Accrued employee expenses 4,328 4,114 Accrued freight 4,028 6,251 Accrued marketing 2,411 3,723 Accrued expenses 8,357 12,023 Total other current liabilities $ 27,385 $ 37,693

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Acquired identifiable intangible assets, and related accumulated amortization, as of March 31, 2022 and December 31, 2021 consist of: March 31, 2022 Gross Carrying Value Accumulated Amortization Net Book Value (in thousands) Customer relationships $ 8,355 $ 6,491 $ 1,864 Tradenames 3,066 807 2,259 Developed technology 1,884 507 1,377 Foreign currency (1,025 ) (989 ) (36 ) Total Intangible Assets $ 12,280 $ 6,816 $ 5,464 December 31, 2021 Gross Carrying Value Accumulated Amortization Net Book Value (in thousands) Customer relationships $ 8,355 $ 6,315 $ 2,040 Tradenames 3,066 730 2,336 Developed technology 1,884 440 1,444 Foreign currency (896 ) (865 ) (32 ) Total Intangible Assets $ 12,409 $ 6,620 $ 5,788
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of March 31, 2022, estimated annual amortization expense related to definite lived intangible assets in future periods is as follows: (in thousands) 2022 $ 961 2023 1,041 2024 1,008 2025 889 2026 637 Thereafter 964 Total $ 5,500

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Summary of Income Tax Expense and Effective Income Tax Rate	The following table presents the Company’s income tax expense and effective income tax rate: Three Months Ended March 31, 2022 2021 (in thousands) Income tax expense (benefit) $ (2,639 ) $ 2,766 Effective income tax rate 29.0 % 23.8 %

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based Compensation Expense	Total estimated stock-based compensation expense for employees and non-employees, related to all of the Company’s stock-based awards, was as follows: Three Months Ended March 31, 2022 2021 (in thousands) Cost of revenue $ 26 $ 397 Selling and marketing 398 331 Research and development 283 249 General and administrative 830 809 Total stock-based compensation $ 1,537 $ 1,786
Stock Activity and Total Number of Shares Available for Grant	The following table presents the stock activity and the total number of shares available for grant as of March 31, 2022: (in thousands) Balance at December 31, 2021 998 Options cancelled 5 Restricted stock granted (43 ) Forfeited/Expired restricted stock added back 5 Balance at March 31, 2022 965
Stock Option Activity	Options Outstanding Number of Shares Underlying Outstanding Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value (in years) Outstanding at December 31, 2021 1,739,240 $ 7.72 $ 7.02 $ 25,542,823 Options Granted - - Options Exercised (47,078 ) 7.67 Options Forfeited (5,198 ) 16.27 Outstanding at March 31, 2022 1,686,964 $ 7.70 6.64 $ 23,231,263 Vested and expected to vest at March 31, 2022 1,666,854 $ 7.75 6.62 $ 22,967,200 Exercisable at March 31, 2022 1,075,419 $ 7.08 6.15 $ 15,595,467
Restricted stock awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Restricted Stock Activity	Shares Weighted Average Grant Date Fair Value Per Share Nonvested restricted stock at December 31, 2021 788,454 $ 16.81 Granted 42,900 23.21 Vested (29,400 ) 20.88 Shares forfeited (4,587 ) 18.75 Nonvested restricted stock at March 31, 2022 797,367 $ 17.00

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Income per Share of Common Stock	The following table sets forth the computation of basic and diluted net income per share of common stock attributable to common stockholders: Three Months Ended March 31, 2022 2021 (in thousands, except per-share data) Net income (loss) $ (6,476 ) $ 8,838 Weighted average common shares outstanding — Basic 16,194 15,551 Plus incremental shares from assumed conversions: Dilutive effect of restricted stock — 517 Dilutive effect of stock options — 1,458 Dilutive effect of warrants — 550 Weighted average common shares outstanding — Diluted 16,194 18,076 Net income (loss) per share: Basic $ (0.40 ) $ 0.57 Diluted $ (0.40 ) $ 0.49
Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Income per Share of Common Stock	Three Months Ended March 31, 2022 2021 (in thousands) Stock options 1,725 97 Unvested restricted stock awards 793 3 Warrants 550 - Total 3,068 100

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Schedule of Total Net Revenues	The following table represents total net revenues based on where customers are physically located: Three Months Ended March 31, 2022 2021 (in thousands) North America $ 31,368 $ 64,135 Europe and Middle East 12,122 26,343 Asia Pacific 3,172 2,575 Total net revenues $ 46,662 $ 93,053

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2022
Commitments And Contingencies Disclosure [Abstract]
Schedule of Product Warranty Liability	The following table provides the changes in our product warranty reserve, which are included in accrued liabilities: Three Months Ended March 31, 2022 2021 (in thousands) Warranty, beginning of period $ 856 $ 1,039 Warranty costs accrued 121 334 Settlements of warranty claims (188 ) (255 ) Warranty, end of period $ 789 $ 1,118
Components of the Right-of-Use Assets and Lease Liabilities	The components of the right-of-use assets and lease liabilities were as follows: Balance Sheet Classification March 31, 2022 (in thousands) Right-of-use assets Other assets $ 8,100 Lease liability obligations, current Other current liabilities $ 1,075 Lease liability obligations, noncurrent Other liabilities 7,430 Total lease liability obligations $ 8,505 Weighted-average remaining lease term (in years) 5.6 Weighted-average discount rate 4.00 %
Schedule of Future Minimum Rental Payments for Operating Leases	Approximate future minimum lease payments for the Company’s right of use assets over the remaining lease periods as of March 31, 2022, are as follows: (in thousands) 2022 $ 986 2023 1,308 2024 1,329 2025 1,315 2026 1,217 Thereafter 3,695 Total minimum payments 9,850 Less: Imputed interest (1,345 ) Total $ 8,505

Fair Value Measurement - Summar

Fair Value Measurement - Summary of Carrying Amounts and Estimated Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Reported Value Measurement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure	$ 23,700	$ 37,720
Estimate of Fair Value Measurement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure	$ 23,700	$ 37,720

Allowance for Sales Returns - S

Allowance for Sales Returns - Schedule of Allowances for Sales Returns (Details) - Sales Returns and Allowances - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance, beginning of period	$ 8,998	$ 11,233
Reserve accrual	2,683	6,551
Recoveries and deductions, net	(5,968)	(5,873)
Balance, end of period	$ 5,713	$ 11,911

Composition of Certain Financ_3

Composition of Certain Financial Statement Items - Schedule of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Condensed Consolidated Balance Sheet Components [Abstract]
Finished goods	$ 116,811	$ 101,446
Raw materials	611	487
Total inventories	$ 117,422	$ 101,933

Composition of Certain Financ_4

Composition of Certain Financial Statement Items - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 30,590	$ 30,058
Less: accumulated depreciation and amortization	(24,297)	(23,103)
Total property and equipment, net	6,293	6,955
Machinery and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	2,317	2,255
Software and software development
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	2,406	2,404
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,422	1,257
Tooling
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	8,036	7,855
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,752	1,794
Demonstration units and convention booths
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 14,657	$ 14,493

Composition of Certain Financ_5

Composition of Certain Financial Statement Items - Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Condensed Consolidated Balance Sheet Components [Abstract]
Accrued royalty	$ 8,261	$ 11,582
Accrued employee expenses	4,328	4,114
Accrued freight	4,028	6,251
Accrued marketing	2,411	3,723
Accrued expenses	8,357	12,023
Total other current liabilities	$ 27,385	$ 37,693

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Finite-lived Intangible Assets [Roll Forward]
Total intangible assets, gross carrying value	$ 12,280	$ 12,409
Finite-lived intangible assets, accumulated amortization	6,816	6,620
Total intangible assets, net book value	5,464	5,788
Total	5,500
Finite-lived intangible assets, gross carrying value	(1,025)	(896)
Finite-lived intangible assets, accumulated amortization	(989)	(865)
Total	(36)	(32)
Customer Relationships
Finite-lived Intangible Assets [Roll Forward]
Finite-lived intangible assets, gross carrying value	8,355	8,355
Finite-lived intangible assets, accumulated amortization	6,491	6,315
Total	1,864	2,040
Trade Names
Finite-lived Intangible Assets [Roll Forward]
Finite-lived intangible assets, gross carrying value	3,066	3,066
Finite-lived intangible assets, accumulated amortization	807	730
Total	2,259	2,336
Developed Technology
Finite-lived Intangible Assets [Roll Forward]
Finite-lived intangible assets, gross carrying value	1,884	1,884
Finite-lived intangible assets, accumulated amortization	507	440
Total	$ 1,377	$ 1,444

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended
	Oct. 31, 2012	Mar. 31, 2022	Mar. 31, 2021
Finite Lived Intangible Assets [Line Items]
Amortization of intangible assets		$ 312,000	$ 303,000
Changes in carrying values of goodwill		$ 0
Acquisition of Lygo International Limited | Customer Relationships
Finite Lived Intangible Assets [Line Items]
Useful life	13 years

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands	Mar. 31, 2022USD ($)
Finite Lived Intangible Assets Future Amortization Expense Current And Five Succeeding Fiscal Years [Abstract]
2022	$ 961
2023	1,041
2024	1,008
2025	889
2026	637
Thereafter	964
Total	$ 5,500

Revolving Credit Facility and_2

Revolving Credit Facility and Long-Term Debt - Additional Information (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2018	Dec. 31, 2021	May 31, 2019
Debt Instrument [Line Items]
Interest expense, debt	$ 100,000	$ 100,000
Amortization of debt financing costs	47,000	$ 47,000
Revolving Credit Facility, Maturing March 2024
Debt Instrument [Line Items]
Expiration date			Mar. 5, 2024
Maximum borrowing capacity			$ 80,000,000
Line of credit facility, capacity available for trade purchases			6,800,000
Line of credit facility, capacity available for specific purpose other than for trade purchases			40,000,000
Outstanding borrowings	$ 0
Debt instrument, covenant, current fixed charge ratio required, minimum	1.00%
Remaining borrowing capacity	$ 48,700,000
Revolving Credit Facility, Maturing March 2024 | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	4.00%
Revolving Credit Facility, Maturing March 2024 | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	3.00%
Revolving Credit Facility, Maturing March 2024 | Minimum
Debt Instrument [Line Items]
Unused commitment fee, percent	0.25%
Revolving Credit Facility, Maturing March 2024 | Minimum | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Revolving Credit Facility, Maturing March 2024 | Minimum | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	1.25%
Revolving Credit Facility, Maturing March 2024 | Minimum | Adjustable Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%
Revolving Credit Facility, Maturing March 2024 | Maximum
Debt Instrument [Line Items]
Unused commitment fee, percent	0.50%
Revolving Credit Facility, Maturing March 2024 | Maximum | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	1.25%
Revolving Credit Facility, Maturing March 2024 | Maximum | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%
Revolving Credit Facility, Maturing March 2024 | Maximum | Adjustable Rate Loans
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%
Revolving Credit Facility, Maturing March 2024 | UK Borrower
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 12,000,000
Revolving Credit Facility, Maturing March 2024 | TB Germany GmbH | Maximum | ROCCAT
Debt Instrument [Line Items]
Line of credit to make investments					$ 4,000,000
Line of credit to make additional investments					$ 4,000,000
Revolving credit facilities
Debt Instrument [Line Items]
Long Term Debt	$ 0			$ 0

Income Taxes - Summary of Incom

Income Taxes - Summary of Income Tax Expense and Effective Income Tax Rate (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ (2,639)	$ 2,766
Effective income tax rate	29.00%	23.80%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ (2,639)	$ 2,766
Effective income tax rate	29.00%	23.80%
Unrecognized tax benefits inclusive of interest and penalties	$ 3,800
Interest and penalties	$ 1,100

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	$ 1,537	$ 1,786
Cost of revenue
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	26	397
Selling and marketing
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	398	331
Research and development
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	283	249
General and administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	$ 830	$ 809

Stock-Based Compensation - St_2

Stock-Based Compensation - Stock Activity and Total Number of Shares Available for Grant (Details)	3 Months Ended
	Mar. 31, 2022shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Shares Available for Grant [Roll Forward]
Balance, beginning of period	998,000
Options cancelled	5,198
Forfeited/Expired restricted stock added back	5,000
Balance, end of period	965,000
Restricted stock awards
Share-based Compensation Arrangement by Share-based Payment Award, Options, Shares Available for Grant [Roll Forward]
Stock granted	(42,900)

Stock-Based Compensation - St_3

Stock-Based Compensation - Stock Option Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding beginning of period (in shares)	1,739,240
Options 'Exercised (in shares)	(47,078)
Options Forfeited (in shares)	(5,198)
Outstanding end of period (in shares)	1,686,964	1,739,240
Vested and expected to vest (in shares)	1,666,854
Exercisable (in shares)	1,075,419
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Outstanding beginning of period (in dollars per share)	$ 7.72
Options 'Exercised (in dollars per share)	7.67
Options Forfeited (in dollars per share)	16.27
Outstanding end of period (in dollars per share)	7.70	$ 7.72
Vested and expected to vest (in dollars per share)	7.75
Exercisable (in dollars per share)	$ 7.08
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Outstanding, weighted average remaining contractual term	6 years 7 months 20 days	7 years 7 days
Vested and expected to vest, weighted average remaining contractual term	6 years 7 months 13 days
Exercisable, weighted average remaining contractual term	6 years 1 month 24 days
Outstanding, intrinsic value	$ 23,231,263	$ 25,542,823
Vested and expected to vest, intrinsic value	22,967,200
Exercisable, intrinsic value	$ 15,595,467

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Forfeiture period after ending employment	90 days
Options exercised, intrinsic value	$ 0.5
Estimated grant date fair value of options vested	$ 3.1
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award expiration period	10 years
Total unrecognized compensation cost	$ 2.5
Compensation cost not yet recognized, period for recognition	1 year 9 months 18 days
Restricted Stock Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total unrecognized compensation cost	$ 10.2
Compensation cost not yet recognized, period for recognition	2 years 3 months 18 days
Outstanding balance	797,367	788,454
Performance Based Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding balance	134,000
Vesting period	3 years
Performance Based Restricted Stock | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Adjusted EBITDA percentage	0.00%
Performance Based Restricted Stock | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Adjusted EBITDA percentage	200.00%
Non-Executives
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Forfeiture rate	10.00%
Executive Officer
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Forfeiture rate	0.00%

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Activity (Details) - Restricted stock awards	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding beginning of period (in shares) | shares	788,454
Granted (in shares) | shares	42,900
Vested (in shares) | shares	(29,400)
Forfeited (in shares) | shares	(4,587)
Outstanding end of period (in shares) | shares	797,367
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Outstanding beginning of period (in dollars per share) | $ / shares	$ 16.81
Granted (in dollars per share) | $ / shares	23.21
Vested (in dollars per share) | $ / shares	20.88
Forfeited (in dollars per share) | $ / shares	18.75
Outstanding end of period (in dollars per share) | $ / shares	$ 17

Net Income (Loss) Per Share - S

Net Income (Loss) Per Share - Schedule of Computation of Basic and Diluted Net Income per Share of Common Stock (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Basic and diluted:
Net income (loss)	$ (6,476)	$ 8,838
Basic:
Weighted-average common shares outstanding, basic (in shares)	16,194	15,551
Incremental Common Shares Attributable to Dilutive Effect of Restricted Stock Awards		517
Dilutive effect of stock options		1,458
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants		550
Diluted:
Weighted-average common shares outstanding, diluted (in shares)	16,194	18,076
Net income (loss) per share:
Basic (in dollars per share)	$ (0.40)	$ 0.57
Diluted (in dollars per share)	$ (0.40)	$ 0.49

Net Income (Loss) Per Share -_2

Net Income (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Income per Share of Common Stock (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	3,068	100
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	1,725	97
Restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	793	3
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	550

Segment Information - Schedule

Segment Information - Schedule of Total Net Revenues (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	$ 46,662	$ 93,053
North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	31,368	64,135
Europe and Middle East
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	12,122	26,343
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	$ 3,172	$ 2,575

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) $ in Millions	3 Months Ended
	Mar. 31, 2022USD ($)	Aug. 10, 2020Motion	May 22, 2020Claim	Aug. 05, 2013
Operating Leased Assets [Line Items]
Number of shareholder claims | Claim			8
Number of motions | Motion		2
Operating lease, expense	$ 0.4
Operating lease, payments	$ 0.2
Minimum
Operating Leased Assets [Line Items]
Operating lease remaining lease term	1 year
Maximum
Operating Leased Assets [Line Items]
Operating lease remaining lease term	9 years
Merger of VTB Holdings, Inc. and Parametric Sound Corporation | VTB Holdings, Inc
Operating Leased Assets [Line Items]
Ownership percentage				80.00%
Merger of VTB Holdings, Inc. and Parametric Sound Corporation | Parametric Sound Corporation
Operating Leased Assets [Line Items]
Ownership percentage				20.00%

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Product Warranty Liability (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]
Warranty, beginning of period	$ 856	$ 1,039
Warranty costs accrued	121	334
Settlements of warranty claims	(188)	(255)
Warranty, end of period	$ 789	$ 1,118

Commitments and Contingencies_3

Commitments and Contingencies - Components of the Right-of-Use Assets and Lease Liabilities (Details) $ in Thousands	Mar. 31, 2022USD ($)
Lessee, Lease, Description [Line Items]
Right-of-use assets	$ 8,100
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other assets
Lease liability obligations, current	$ 1,075
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other current liabilities
Lease liability obligations, noncurrent	$ 7,430
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other liabilities
Total lease liability obligations	$ 8,505
Weighted-average remaining lease term (in years)	6 years 3 months 18 days
Weighted Average
Lessee, Lease, Description [Line Items]
Weighted-average discount rate	4.00%

Commitments and Contingencies_4

Commitments and Contingencies - Schedule of Future Minimum Rental Payments for Operating Leases (Details) $ in Thousands	Mar. 31, 2022USD ($)
Commitments And Contingencies Disclosure [Abstract]
2022	$ 986
2023	1,308
2024	1,329
2025	1,315
2026	1,217
Thereafter	3,695
Total minimum payments	9,850
Less: Imputed interest	(1,345)
Total	$ 8,505